Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Treatment Options in Oncology

Issue 6/2006

Content (9 Articles)

Gastrointestinal stromal tumors: Imatinib and beyond

Ian D. Schnadig, Charles D. Blanke

The enigma of desmoid tumors

Scott Okuno

Management of osteosarcoma

Jeremy Whelan, Beatrice Seddon, Martha Perisoglou

Adjuvant therapy for extremity sarcomas

Michael Schlieman, Richard Smith, William G. Kraybill

Chemotherapeutic options for primary brain tumors

Lyndon Kim, Michael Glantz

Current therapeutic approaches in patients with brain metastases

Kevin H. Peacock, Glenn J. Lesser

Predictive and prognostic markers in human glioblastomas

Kamalakannan Palanichamy, Michael Erkkinen, Arnab Chakravarti

Management of pineal region tumors

Jaishri O. Blakeley, Stuart A. Grossman

Managing the cognitive effects of brain tumor radiation therapy

Jerome M. Butler, Stephen R. Rapp, Edward G. Shaw

Oct 06
Issue: 5/2006
Feb 07
Issue: 1/2007

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits